First and only therapeutic drug for ALK-positive lung cancer approved
Wednesday, August 31, 2011 - 12:30
in Health & Medicine
In a major triumph for personalized medicine, the FDA approved the drug crizotinib for use with the lung cancer type known as ALK-positive.